Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
8.12
-0.16 (-1.93%)
At close: May 9, 2025, 4:00 PM
8.12
0.00 (0.00%)
After-hours: May 9, 2025, 7:57 PM EDT
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $841.10 million as of May 9, 2025. Its market cap has decreased by -59.35% in one year.
Market Cap
841.10M
Enterprise Value
189.57M
1-Year Change
-59.35%
Ranking
Category
Stock Price
$8.12
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $841.10M, an increase of 11.04%. That is a compound annual growth rate of 1.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 857.10M | -27.83% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.69B |
| Johnson & Johnson | 374.82B |
| UnitedHealth Group | 348.44B |
| AbbVie | 334.87B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 234.11B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |